Evaluation of cisplatin + 5-FU, carboplatin + 5-FU, and ifosfamide + epirubicine regimens using the micronuclei test and nuclear abnormalities in the buccal mucosa

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 539, Issue 1-2, 2003, Pages 177-186

  Torres Bugarin O ^a,b   Ventura Aguilar, A ^b   Zamora Perez, A ^b,c   Gomez Meda B C ^b,c   Ramos Ibarra, M L ^b,c   Morgan Villela, G ^b   Gutierrez Franco A ^a   Zuniga Gonzalez G ^b  

^a UNIVERSIDAD AUTÓNOMA DE GUADALAJARA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

5 FU; Buccal mucosa; Carboplatin; Cisplatin; Epirubicine; Ifosfamide; Micronuclei; Nuclear abnormalities

Indexed keywords

CARBOPLATIN; CISPLATIN; EPIRUBICIN; FLUOROURACIL; IFOSFAMIDE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CELL COUNT; CHEEK MUCOSA; CHROMATIN CONDENSATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; FEMALE; GENOTOXICITY; HUMAN; HUMAN TISSUE; MALE; MICRONUCLEUS; MICRONUCLEUS TEST; PRIORITY JOURNAL; TOXICITY TESTING;

EID: 0042388506     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(03)00163-3     Document Type: Article

References (33)

1. Fenech M., Holland N., Chang W.P., Zeiger E., Bonnassi S. The human micronucleus project: an international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat. Res. 428:1999;271-283.
2. Livingston G.K., Reed R.N., Olson B.L., Lockey J.E. Induction of nuclear aberrations by smokeless tobacco in epithelial cells of human oral mucosa. Environ. Mol. Mutagen. 15:1990;136-144.
3. Kayal J.J., Triedi A.H., Dave B.J., Nair J., Bhide S.V., Goswami U.C., Adhvaryu S.G. Incidence of micronuclei in oral mucosa of users of tobacco products singly or in various combinations. Mutagenesis. 8:1993;31-33.
4. Ozkul Y., Donmez H., Erenmemisoglu A., Demirtas H., Imamoglu N. Induction of micronuclei by smokeless tobacco on bucal mucosa cells of habitual users. Mutagenesis. 4:1997;285-287.
5. Nair U.S., Obe G., Nair J., Maru G.B., Bhide S.V., Pieper R., Bartsch H. Evaluation of frequency of micronucleated oral mucosa cells as a marker for genotoxic damage in chewers of betel quid with or without tobacco. Mutat. Res. 261:1991;163-168.
6. Stich H.F., San H.C., Rosin M.P. Adaptation of the DNA-repair and micronucleus test to human cell suspensions and exfoliated cells. Ann. N. Y. Acad. Sci. 407:1983;93-105.
7. Sarto F., Finotto S., Giacomelli L., Mazzotti D., Tomanin R. The micronucleus assay in exfoliated cells of the human buccal mucosa. Mutagenesis. 2:1987;11-17.
8. Nersesian A.K., Zil'fian V.N., Kumkumdzhian V.A., Nerseisan A.K. An analysis of the micronuclei in the oral mucosa of cancer patients for assessing the clastogenic effect of chemical preparations. Tsitol. Genet. 27:1993;77-80.
9. Rodríguez-Vázquez M., Sánchez-Ortiz A., Ramos-Remus C., Zúñiga G., Torres-Bugarín O. Evaluación de la genotoxicidad de ciclofosfamida mediante prueba de micronúcleos en pacientes con lupus eritematoso sistémico. Rev. Mex. Reumatol. 15:2000;41-45.
10. Ogden G.R., Cowpe J.G., Wight A.J. Oral exfoliative cytology: review of methods of assessment. J. Oral Pathol. Med. 26:1997;201-210.
11. L.C. Junqueira, J. Carneiro, R.O. Kelley, Basic Histology, Appleton & Lange, USA, 1998, pp. 51, 347.
12. Shuilin H., Beker R. Initiating carcinogen, trithylenemelamine, induces micronuclei in skin target cells. Environ. Mol. Mutagen. 14:1989;1-5.
13. Torres-Bugarín O., De Anda-Casillas A., Ramírez-Muñoz M.P., Sánchez-Corona J., Cantú J.M., Zúñiga G. Determination of diesel genotoxicity in firebreather by micronuclei and nuclear abnormalities in buccal mucosa. Mutat. Res. 413:1998;277-281.
14. Tolbert P.E., Shy A.C., Allen J.W. Micronuclei and other nuclear abnormalities in buccal smears: a field-test in snuff users. Am. J. Epidemol. 134:1991;840-850.
15. Tolbert P.E., Shy A.C., Allen J.W. Micronuclei and other nuclear abnormalities in buccal smears: methods development. Mutat. Res. 271:1992;69-77.
16. V.T. De Vita, S. Hellman Jr., A. Steven, M.D. Rosenberg, Oncology: Principles and Practice of Oncology, Multimedia, Lippincott/Raven, USA, 1997.
17. Jagetia G.C., Jayakrishnan A., Fernandes D., Vidyasagar M.S. Evaluation of micronuclei frequency in the cultured peripheral blood lymphocytes of cancer patients before and after radiation treatment. Mutat. Res. 491:2001;9-16.
18. E. Rubin, J. Farber, Pathology, Lippincott/Raven, USA, 1999, pp. 155-164, 1581-1583.
19. Baciuchka-Palmaro M., Orsiére T., Duffaud F., Sari-Minodier I., Pompili J., Bellon L., De Méo M., Digue L., Favre R., Botta A. Acentromeric micronuclei are increased in peripheral blood lymphocytes of untreated cancer patients. Mutat. Res. 520:2002;189-198.
20. Migliore L., Bevilacqua C., Sccarpato R. Cytogenetic study and FISH analysis in lymphocytes of systemic lupus erythematosus (SLE) and systemic sclerosis (SS) patients. Mutagenesis. 14:1999;227-231.
21. Ramos-Remus C., Dorazco-Barragan G., Alcaraz-Lopez F.J., Fuentes-Ramirez F., Michel-Díaz J., Torres-Bugarin O., Ventura-Aguilar A., Zúñiga-González G. Genotoxicity assessment using micronuclei assay in rheumatoid arthritis patients. Clin. Exp. Rheumatol. 20:2002;208-212.
22. Vock E.H., Lutz W.K., Hormes P., Hoffmann H.D., Vamvakas S. Discrimination between genotoxicity and cytotoxicity in the induction of DNA double-strand breaks in cells treated with etoposide, melphalan, cisplatin, potassium cyanide, Triton X-100, and gamma-irradiation. Mutat. Res. 413:1998;83-94.
23. Jirova K., Mands V. Induction of micronuclei and granular chromatin condensation in human skin fibroblasts influenced by cisplatin (cis-CDDP) in vitro. Mutat. Res. 310:1994;37-44.
24. Chodhury R.C., Jagdale M.B., Misra S. Cytogenetic toxicity of cisplatin in bone marrow cells of Swiss mice. J. Chemother. 12:2000;173-182.
25. Zúñiga G., Torres-Bugarín O., Ramírez-Muñoz M.P., Delgado-Lamas J.L., De Loza-Saldaña R., Cantú J.M. Micronucleated erythrocytes in splenectomized patients with and without chemotherapy. Mutat. Res. 361:1996;107-112.
26. Torres-Bugarín O., Zamora-Perez A.L., Esparza-Flores A., Lopez-Guido B., Feria-Velasco A., Cantú J.M., Zúñiga G. Eritrocitos micronucleados en niños esplenectomizados con y sin quimioterapia. Bol. Med. Hosp. Infant. Mex. 56:1999;212-217.
27. Heddle J.A., Hite M., Kirthart B.K., Mavournin J.T., MacGregor G., Newell W., Salamaone M.F. The induction of micronuclei as a measure of genotoxicity. A report of the US Environmental Protection Agency Gene-tox Program. Mutat. Res. 123:1983;61-118.
28. Au W.W., Sierra-Torres C.H., Cajas-Salazar N., Salama S.A. Inheritance of polymorphic metabolizing genes in environmental disease and quality of life. Mutat. Res. 428:1999;131-140.
29. Hahn K.A., Legendre A.M., Talbott J.R. The frequency of micronuclei in lymphocytes of dogs with osteosarcoma: a predictive variable for tumor response during cisplatin chemotherapy. Cancer Epidemiol. Biomarkers Prev. 5:1996;653-656.
30. Lee T.K., O'Brien K.F., Naves J.L., Christie K.I., Arastu H.H., Eaves G.S., Wiley A.L., Karlsson U.L., Salehpour M.R. Micronuclei in lymphocytes of prostate cancer patients undergoing radiation therapy. Mutat. Res. 469:2000;63-70.
31. B. Djulbegovic, D. Sullivan, Decision Making in Oncology Evidence-Based Management, Churchill-Livingston, New York, 1997, pp. 1-14.
32. W.B. Pratt, R.W. Ruddon, W.D. Ensminger, J. Maybaum, The Anticancer Drugs, second ed., Oxford University Press, New York, 1994, pp. 575-590.
33. Nagae Y., Miyamoto H., Suzuki Y., Shimizu H. Effect of induction of micronuclei by mutagens in male mice. Mutat. Res. 263:1991;21-26.